Foreign Policy Journal
September 2027 Will Be The Real Test For Rocket Lab's (NASDAQ: RKLB) Deep-Space Ambitions After Mars Burn Success
• Rocket Lab completed trans-Mars injection burns for NASA's twin ESCAPADE spacecraft, which it built and operates.
• Analysts see Space Systems and full-mission contracts, not Electron launches, as the bigger growth driver.
• Shares fell 7.05% despite the milestone; fair value estimate stands at $98.25 ahead of Sept 2027 Mars orbit insertion.
Rocket Lab (NASDAQ: RKLB) completed trans-Mars injection burns for NASA's twin ESCAPADE spacecraft, autonomously setting both vehicles on course for Mars. Unlike a standard launch contract, Rocket Lab designed, built, and operates both spacecraft for NASA and UC Berkeley, showcasing its Explorer-class platform and in-house components in deep space.
Analysts say the bigger growth story is Space Systems and full-mission contracts rather than Electron launch sales, part of a broader push into larger defense contracts and a vertically integrated platform involving Iridium. Still, shares fell 7.05% on the news, underscoring that technical milestones don't always move the stock.
Fair value models currently peg the stock at $98.25, contingent on Space Systems converting its demonstrated capability into sustained revenue and margin growth. Upcoming quarterly results will be watched for Space Systems revenue and margins ahead of the spacecrafts' September 2027 Mars orbit insertion attempt, a major test for both the mission and Rocket Lab's commercial standing. Analysts have also flagged three separate warning signs investors should weigh.
November 22, 2026 at 7:04 AMFVRRKLB